Drugs & Targets FDA Updates Zytiga Label To Include Chemotherapy-Naive Metastatic CRPC Data April 30, 2015Vol.38 No.04
Three Xtandi Trials Show Positive Results In Castration-Resistant Prostate Cancer April 30, 2015Vol.38 No.04
Baselga Becomes AACR President. Two SU2C Dream Teams Launched, And Multiple Award Winners Named April 24, 2015Vol.41 No.16
Conversation with The Cancer Letter Wender: Mammography Guidelines Should Balance Benefits and Risks, Not Costs April 24, 2015Vol.41 No.16By Matthew Bin Han Ong
Conversation with The Cancer Letter Costs of Harm from Mammography Must Be Balanced Against Benefits April 24, 2015Vol.41 No.16By Matthew Bin Han Ong
Mammography: When, Really, is the Right Time? And at What Cost? April 24, 2015Vol.41 No.16By Matthew Bin Han Ong
Foes Immediately Vow to Nullify Task Force Guideline on Mammography for Women 40-49 April 24, 2015Vol.41 No.16By Paul Goldberg
MD Anderson Execs Get Big Raises In the Midst of Faculty Morale Woes April 17, 2015Vol.41 No.15By Paul Goldberg
